Publications (38) MARIA VICTORIA GONZALEZ MEANA publications

2023

  1. Abrogation of stemness in osteosarcoma by the mithramycin analog EC-8042 is mediated by its ability to inhibit NOTCH-1 signaling

    Biomedicine and Pharmacotherapy, Vol. 162

2020

  1. GARP promotes the proliferation and therapeutic resistance of bone sarcoma cancer cells through the activation of TGF-β

    Cell Death and Disease, Vol. 11, Núm. 11

  2. Sox2 expression and transcriptional activity identifies a subpopulation of cancer stem cells in sarcoma with prognostic implications

    Cancers, Vol. 12, Núm. 4

2018

  1. FUS-CHOP Promotes Invasion in Myxoid Liposarcoma through a SRC/FAK/RHO/ROCK-Dependent Pathway

    Neoplasia (United States), Vol. 20, Núm. 1, pp. 44-56

  2. TP53 p.R72P genotype is a marker of poor prognosis in lung cancer

    Cancer Biomarkers, Vol. 21, Núm. 4, pp. 747-754

2016

  1. Impact of PI3K/AKT/mTOR pathway activation on the prognosis of patients with head and neck squamous cell carcinomas

    Oncotarget, Vol. 7, Núm. 20, pp. 29780-29793

  2. Osteosarcoma: Cells-of-Origin, Cancer stem cells, and targeted therapies

    Stem Cells International, Vol. 2016

2014

  1. Prognostic and diagnostic value of epithelial to mesenchymal transition markers in pulmonary neuroendocrine tumors

    BMC Cancer, Vol. 14, Núm. 1

2013

  1. Epithelial-mesenchymal transition markers in the differential diagnosis of gastroenteropancreatic neuroendocrine tumors

    American Journal of Clinical Pathology, Vol. 140, Núm. 1, pp. 61-72

2010

  1. Podoplanin expression in the development and progression of laryngeal squamous cell carcinomas

    Molecular Cancer, Vol. 9

  2. Prognostic significance of lymphangiogenesis in pharyngolaryngeal carcinoma patients

    BMC Cancer, Vol. 10

  3. Snail nuclear expression parallels higher malignancy potential in neuroendocrine lung tumors

    Lung Cancer, Vol. 69, Núm. 3, pp. 289-295

2009

  1. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas

    Journal of Pathology, Vol. 217, Núm. 4, pp. 516-523

  2. Oncogene amplification pattern in adenoid cystic carcinoma of the salivary glands

    Oncology Reports, Vol. 21, Núm. 5, pp. 1215-1222

2008

  1. Annexin A2 localizes to the basal epithelial layer and is down-regulated in dysplasia and head and neck squamous cell carcinoma

    Cancer Letters, Vol. 263, Núm. 1, pp. 89-98

  2. Skp2, p27kip1 and EGFR assessment in head and neck squamous cell carcinoma: Prognostic implications

    Oncology Reports, Vol. 20, Núm. 3, pp. 589-595

2007

  1. Epithelial cell nicotinic acetylcholine receptor expression in head and neck squamous cell carcinoma pathogenesis

    Anticancer Research, Vol. 27, Núm. 2, pp. 835-839

  2. Human DESC1 serine protease confers tumorigenic properties to MDCK cells and it is upregulated in tumours of different origin

    British Journal of Cancer, Vol. 97, Núm. 2, pp. 201-209

2006

  1. Amplification of CCND1, EMS1, PIK3CA, and ERBB oncogenes in ethmoid sinus adenocarcinomas

    Otolaryngology - Head and Neck Surgery, Vol. 135, Núm. 1, pp. 135-139

2004

  1. Amplificación del gen de la ciclina D1 en los carcinomas adenoides quísticos de glándulas salivares menores

    Acta Otorrinolaringologica Espanola, Vol. 55, Núm. 2, pp. 88-92